Popovits Kimberly J

CIK 000133348210 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001333482

Recent Transactions

50 trades

Award
Kardigan, Inc.$KARD
Common Stock
2026-06-17+20,706→ 20,706 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2026-06-04+8,829→ 37,445 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-05-29+2,799→ 15,345 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2026-05-29+2,026→ 2,026 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-05-29+12,158→ 12,158 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2026-05-29−2,799→ 0 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Stock Options (Right to Buy)
2026-04-01+10,257→ 10,257 total
Award
RHYTHM PHARMACEUTICALS, INC.$RYTM
Restricted Stock Units
2026-04-01+6,808→ 6,808 total
Disposition to Issuer
EXACT SCIENCES CORP$EXAS
Common Stock
2026-03-23−6,725→ 9,656 total
Disposition to Issuer
EXACT SCIENCES CORP$EXAS
Common Stock
2026-03-23−9,656→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-07-30$10.36/sh+45,748→ 58,294 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-07-30$15.47/sh+18,760→ 77,054 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-07-30−45,748→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-07-30−18,760→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-07-30$29.90/sh−64,508→ 12,546 total
Award
EXACT SCIENCES CORP$EXAS
Common Stock
2025-06-12+9,994→ 16,381 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-05−3,173→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-05+3,173→ 12,546 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-03+2,799→ 2,799 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2025-06-03+15,357→ 28,616 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-06-03+16,798→ 16,798 total
Award
EXACT SCIENCES CORP$EXAS
Common Stock
2025-01-02+6,387→ 6,387 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2024-06-11+8,649→ 13,259 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-06-06−4,373→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2024-06-06+4,373→ 9,373 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-06-05+3,173→ 3,173 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2024-06-05+19,040→ 19,040 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2023-06-29−5,000→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2023-06-29+5,000→ 5,000 total
Award
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2023-06-14+4,661→ 4,661 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2023-06-14+1,865→ 4,610 total
Award
Talis Biomedical Corp$TLIS
Stock option (right to buy)
2023-06-09+95,000→ 95,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2023-06-06+4,373→ 4,373 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2023-06-06+26,236→ 26,236 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2022-06-29+5,000→ 5,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2022-06-29+30,000→ 30,000 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2022-06-15+2,120→ 2,745 total
Award
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2022-06-15+5,300→ 5,300 total
Award
Talis Biomedical Corp$TLIS
Stock Option (right to buy)
2022-06-10+95,000→ 95,000 total
Award
Talis Biomedical Corp$TLIS
Stock Option (right to buy)
2021-08-30+550,000→ 550,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2021-06-29+33,237→ 33,237 total
Award
10x Genomics, Inc.$TXG
Stock Option (right to buy)
2021-06-11+1,563→ 1,563 total
Award
10x Genomics, Inc.$TXG
Class A Common Stock
2021-06-11+625→ 625 total
Conversion
Talis Biomedical Corp$TLIS
Series F-1 Preferred Stock
2021-02-17−128,655→ 0 total
Conversion
Talis Biomedical Corp$TLIS
Series E-1 Preferred Stock
2021-02-17−131,642→ 0 total
Conversion
Talis Biomedical Corp$TLIS
Series E-1 Preferred Stock
2021-02-17−300,000→ 0 total
Conversion
Talis Biomedical Corp$TLIS
Series C-1 Preferred Stock
2021-02-17−31,519→ 0 total
Conversion
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17+89,968→ 182,025 total
Conversion
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17+92,057→ 92,057 total
Purchase
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17$16.00/sh+5,300→ 215,090 total

Companies

Recent Filings

Address

C/O KARDIGAN, INC. 506 CARNEGIE CENTER DRIVE, SUITE 201

PRINCETON, NJ, 08540

View on SEC.gov